SCI Abstract

search
+
Guselkumab in Behcets disease
Guselkumab in Behcets disease
The mucocutaneous and articular clinical phenotype is the most common presentation of Behçet’s disease (BD).1 Current trea...
Mystery of hidden pearls: bursitis in the shoulder
Mystery of hidden pearls: bursitis in the shoulder
A woman aged 52 years, known to have rheumatoid arthritis for 12 years, presented with worsening of joint pain for 2 weeks...
Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases
Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases
StarterRaoul Dufy received corticosteroid therapy in 1950 as one of the first patients to be treated with cortisone to rel...
Ruxolitinib as a salvage therapy in adult-onset macrophage activation syndrome: insights from eight cases
Ruxolitinib as a salvage therapy in adult-onset macrophage activation syndrome: insights from eight cases
Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic disorder characteristic by excessive ...
Systemic juvenile idiopathic arthritis and adult-onset Stills disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Stills disease
Systemic juvenile idiopathic arthritis and adult-onset Stills disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Stills disease
IntroductionStill’s disease was described in children in 1897 by Sir George Frederick Still and is today called systemic j...
Efficacy and safety of therapies for Stills disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Stills disease
Efficacy and safety of therapies for Stills disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Stills disease
IntroductionAdult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA) are the adult and child c...
Plasma proteome profiling in giant cell arteritis
Plasma proteome profiling in giant cell arteritis
IntroductionEarly in its disease course, giant cell arteritis (GCA) can cause irreversible vision loss and cerebrovascular...
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
MethodsWe followed the standardised operating procedures for the development of EULAR-endorsed recommendations and employe...
B-cell depletion in autoimmune diseases
B-cell depletion in autoimmune diseases
B cells have a pivotal function in the pathogenesis of autoimmune diseases, such as rheumatoid arthritis, multiple scleros...
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial
Video Abstract Disclaimer: this video summarises a scientific article published by BMJ Publishing Group Limited (BMJ). The...
Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update by Fanouriakis et al
Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update by Fanouriakis et al
We read with great interest the new EULAR guidelines1 for the management of systemic lupus erythematosus (SLE), and we app...
Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update by Fanouriakis et al
Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update by Fanouriakis et al
We thank Drs Roberts et al for their interest in the updated EULAR recommendations for the management of systemic lupus er...
Correspondence on 'Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis by Kim et al
Correspondence on 'Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis by Kim et al
Kim et al recently published a ‘population-based nationwide cohort study’, a currently popular study type.1 It concludes t...
Referral of patients with suspected polymyalgia rheumatica: how complete is our view of 'planet PMR?
Referral of patients with suspected polymyalgia rheumatica: how complete is our view of 'planet PMR?
Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease after rheumatoid arthritis in person...
Correction: Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy
Correction: Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy
Ingegnoli F, Cincinelli G, Luppino AF, et al. Ensuring tight control in patients with rheumatoid arthritis treated with ta...
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
WHAT IS ALREADY KNOWN ON THIS TOPICAchieving low disease activity in the absence of corticosteroids remains an important t...
HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis
HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis
The pathogenesis of axial spondyloarthritis (axSpA), although not entirely clear yet, is largely based on genes, the stron...
Pathological autoantibody internalisation in myositis
Pathological autoantibody internalisation in myositis
WHAT IS ALREADY KNOWN ON THIS TOPICAutoantibodies targeting intracellular proteins are common in various autoimmune diseas...
Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasus arteritis
Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasus arteritis
IntroductionTakayasu’s arteritis (TAK) is a chronic large-vessel vasculitis (LVV) characterised by inflammation of the aor...
Paraspinal tophi
Paraspinal tophi
A young adult patient with gout was incidentally found to have a large mass on the right lumbar spine and sacrum during an...
Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study)
Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study)
WHAT IS ALREADY KNOWN ON THIS TOPICMesenchymal stromal cells have been shown to reduce disc inflammation and enhance carti...
Response to: Correspondence on 'Current myositis clinical trials and tribulations by Saygin et al
Response to: Correspondence on 'Current myositis clinical trials and tribulations by Saygin et al
We thank Azevedo et al 1 for their correspondence in response to the publication of our viewpoint entitled ‘Myositis Clini...
Dysregulation of immune checkpoint molecules as a characteristic of autoimmune congenital heart block
Dysregulation of immune checkpoint molecules as a characteristic of autoimmune congenital heart block
Autoimmune congenital heart block (CHB) represents a severe manifestation of neonatal lupus syndrome due to placental tran...
Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment?
Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment?
There is a growing appreciation that both giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely interrel...
Annals of the Rheumatic Diseases collection on pregnancy 2018-2023: observational data-driven knowledge
Annals of the Rheumatic Diseases collection on pregnancy 2018-2023: observational data-driven knowledge
Pregnancy can be an exciting time but for those living with rheumatic musculoskeletal diseases (RMDs), it can also be a ti...
Kauko Vainio (1913-1989): pioneer of rheumaorthopaedic surgery
Unfortunately the page "wp-signup.php" you are looking for cannot be found. This may be the result of a broken link o...
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease
IntroductionBoth rheumatic musculoskeletal diseases (RMDs) and cancer occur frequently in the general population and these...
Expression of HIF1{alpha} in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery
Expression of HIF1{alpha} in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery
WHAT IS KNOWN ON THIS TOPICWHAT THIS STUDY ADDSThis study shows that the death of intestinal epithelial cells via necropto...
Characterisation of choroid plexus-infiltrating T cells reveals novel therapeutic targets in murine neuropsychiatric lupus
Characterisation of choroid plexus-infiltrating T cells reveals novel therapeutic targets in murine neuropsychiatric lupus
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study
IntroductionSerological activity in systemic lupus erythematosus (SLE) generally refers to the presence of anti-dsDNA anti...
Load More
format_indent_increase